Patient choice and narrow networks can and should be aligned, and tech investments can make this possible.
Category: Forbes
As Amazon Lurks, Walgreens Launches Digital Marketplace Listing Providers And Prices
Walgreens is launching a new digital marketplace to connect mobile visitors to drugstores, doctors and health clinics in communities across the U.S.
Hennepin Ketamine Study Raises Questions About Ethics And Consent
A trial of ketamine, given by paramedics for agitated patients, is raising multiple ethical concerns and impact other clinical trials.
Viagra Inventor Raises $10m To Find Medicines For Rare Diseases With AI
Dr David Brown’s latest company is called Healx and it’s using machine learning to see how existing drugs can be used to treat rare diseases.
If You Want To Start Businesses, Will This Cat Poop Parasite Help?
A study found an interesting relationship between exposure to Toxoplasma gondii, a parasite that can be found in cat feces, and entrepreneurship. But beware.
Demi Lovato’s Struggle With Addiction Highlights The Risk of Relapse
As we learned about Demi Lovato’s hospitalization related to reported heroin use yesterday, the reality is that beating addiction and staying sober over the long term is not an easy feat to accomplish.
Evidence Mounts That Germs May Cause Alzheimer’s
“The two biggest threats to healthy aging have had to do with dealing with infection…Now we are looking for viruses in all of the major life-threatening diseases of our time—Alzheimer’s, cancer, Parkinson’s—and guess what? Infection is now cropping u…
Ahead Of Second Quarter Earnings Call, Gilead CEO Resigns
Just before Gilead Sciences released its second quarter earnings Wednesday after the close of markets, the company announced in a separate statement that CEO John Milligan has resigned.
Biogen And Eisai Present Positive Results For Experimental Alzheimer’s Drug
Drugmakers Eisai and Biogen presented positive results of their much-anticipated experimental Alzheimer’s drug BAN-2401 today at the Alzheimer’s Association International Conference in Chicago. But doctors still have questions.
New ‘Double Hit’ Strategy May Provide New, Minimally Toxic Therapies For Breast Cancer
New research has identified a potential new target for therapies that could be used in triple-negative breast cancer, while sparing healthy cells.
